Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
2
×
indiana blog main
indiana top stories
2
×
life sciences
national blog main
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astrazeneca
biogen
bluerock therapeutics
boston blog main
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cancer
cancer immunotherapy
cerovene
chronic migraine
covid-19
crispr
deals
deerfield management
detroit blog main
detroit top stories
drugs
durvalumab
editas medicine
eli lilly
episodic migraine
europe blog main
europe top stories
forty seven
What
announced
2
×
medicines
acquisitions
approval
approved
bio
ceo
class
collabs
covid
daniel
deal
decision
developed
drug
eli
fda
gilead
gilead’s
headache
help
introduce
ipo
late
lilly
marks
migraine
month
new
o’day
pain
plans
prevent
roundup
sciences
starts
thursday
transformative
won
years
Language
unset
Current search:
announced
×
fda
×
" indiana top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines